Bio and Beyond

16 Minutes: Steam Halts Web3 Games; FDA Approves Prostate Cancer AI

Jonathan Lai, Eddy Lazzarin, Vineeta Agarwala, Jay Rughani, Eliezer Van Allen, and Zoran Basich

We explore trends behind the news of a gaming giant barring blockchain-based games, and a new tool to help pathologists identify cancer from images.

The Age of Tech x Bio: The ‘Industrial Bio Complex’

Vijay Pande

A new era of industrialized bio is the next industrial revolution, propelled forward by Covid as our gen’s World War II. And with it we'll now see bio's GAFA...

Global Labs Pose Major Threat — Here’s What U.S. Should Do

Scott Gottlieb

Labs classified as BSL-4 are being built all around the world, many in countries with a history of poor controls and oversight of research practices.

Uncontrolled Spread: Science, Policy, Institutions, Infrastructure

Scott Gottlieb, Vineeta Agarwala, Marc Andreessen, and Vijay Pande

We were at an inflection point with the COVID pandemic, between old and new tech, science institutions, policy, more. So what can we learn from past for future?

The Average American Would Pay $242,000 For One Extra Year of Good Health

Andrew Scott

New economic research supports a shift from the pursuit of longevity at all costs to a focus on healthspan: more healthy time over the duration of one’s life.

Platform-Partnership Fit for Bio Startups

Jorge Conde and Jay Rughani

As a new bio platforms becomes more broadly productive than ever before, it's even more important for startups to find platform, and partnership, fit.

Extinction Isn’t an End: Mining Ancient Innovation for Future Solutions

Betül Kaçar

It's easy to think extinction equals failure, but in fact, past life may encode the solutions to our most pressing future problems.

Compete or Connect: Scalable Business Models in Bio

Vineeta Agarwala

Which bio companies will have the greatest impact and scale? Which business models will endure the test of time? In short, those that "Compete or Connect"!

An “Omics” Answer to the Replication Crisis

Malcolm MacLeod

One possible solution to the replication crisis is to apply big data, "omics"-like approaches to the scientific literature: aka Publomics.

AI is Too Dumb… For Now

Vijay Pande

AI can revolutionize healthcare and the life sciences. But the reality, in practice, is that the potential of AI will be limited — unless it gets a lot smarter.